Background: Cardiovascular disease is costly, and annual expenditures are projected to
increase. Our objective was to examine the variation in patient-level costs and identify …

Background The clinical value and cost-effectiveness of invasive treatments for patients with
coronary artery disease is unclear. Invasive treatments such as coronary artery bypass …

The legitimacy of expensive revascularization procedures in patients with stable coronary
artery disease (CAD) remains to be seen. In this study, resource utilization was compared …

Patients with ongoing angina despite optimal medical management who have limited
available revascularization options are a challenging population. 1–3 Although mortality …

OBJECTIVE--To investigate the possibility of an association between the duration of medical
treatment before coronary angiography and demographic and non-clinical factors. DESIGN …

Background Stable coronary artery disease (CAD) affects approximately 7% of the
population of Hong Kong and is associated with substantial healthcare costs. Objective We …

Background: The ratio of revascularization to medical therapy (referred to herein as the
revascularization ratio) for the initial treatment of stable ischemic heart disease varies …

Background Acute coronary syndromes account for half of all deaths secondary to
cardiovascular disease and represent a significant economic burden in the United States …

Background Cost studies appear sporadically in the scientific literature and are rarely
revised unless drastic technological advancements occur. However, health technologies …

Objectives: The study assessed the appropriateness of coronary revascularization in
Ontario, Canada, and examined its association with longer-term outcomes. Background …